✦ LIBER ✦

Accuracy of RECIST 1.1 for non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors

✍ Scribed by Sun, Jong-Mu; Ahn, Myung-Ju; Park, Min Jae; Yi, Jun Ho; Kim, Tae Sung; Chung, Myung Jin; Park, Yeon Hee; Ahn, Jin Seok; Park, Keunchil

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characterization of skin pathology in no

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Volumetric tumor growth in advanced non-

✍ Nishino, Mizuki; Dahlberg, Suzanne E.; Cardarella, Stephanie; Jackman, David M.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Plasma MIP-1β levels and skin toxicity i

✍ Kimura, Hideharu; Kasahara, Kazuo; Sekijima, Masaru; Tamura, Tomohide; Nishio, K 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Tyrosine kinase inhibitors with antiangi

✍ Nguewa, Paul A; Calvo, Alfonso; Pullamsetti, Soni Savai; Banat, Gamal Andre; Gri 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 467 KB

Which tyrosine kinase inhibitor should b

✍ Alfredo Tartarone,Rosa Lerose,Chiara Lazzari,Vanesa Gregorc… 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 284 KB

Disease Flare After EGFR Tyrosine Kinase

✍ Hua-Jun Chen, Hong-Hong Yan, Jin-Ji Yang, Zhi-Hong Chen… 📂 Article 📅 2013 🏛 Springer Netherlands 🌐 English ⚖ 214 KB